Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 124,664 | 100,526 | 126,224 | 62,535 | 100,041 |
| Depreciation Amortization | 22,509 | 23,007 | 16,843 | 16,110 | 13,482 |
| Income taxes - deferred | -2,423 | -3,635 | 699 | 19,306 | -3,700 |
| Accounts payable and accrued liabilities | 6,076 | 1,835 | -1,720 | 3,043 | -1,341 |
| Other Working Capital | 556 | -8,790 | -7,749 | 7,589 | 10,410 |
| Other Operating Activity | 9,019 | 13,790 | 17,822 | 15,191 | 17,999 |
| Operating Cash Flow | $160,401 | $126,733 | $152,119 | $123,774 | $136,891 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,088 | -16,552 | -11,052 | -13,198 | -32,687 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -7 |
| Purchase Of Investment | -20,000 | N/A | -86,396 | N/A | N/A |
| Sale Of Investment | N/A | 63,539 | 22,857 | N/A | N/A |
| Other Investing Activity | 1,127 | 507 | 5,588 | 296 | 811 |
| Investing Cash Flow | $-33,961 | $47,494 | $-69,003 | $-12,902 | $-31,883 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 60,000 | 5,000 | N/A | 3,500 | 73,700 |
| Common Stock Repurchased | -57,029 | -150,000 | -105,375 | -50,000 | -64,610 |
| Other Financing Activity | -62,413 | -7,052 | 98 | -3,816 | -73,950 |
| Financing Cash Flow | $-59,442 | $-152,052 | $-105,277 | $-50,316 | $-64,860 |
| Exchange Rate Effect | 11,251 | -1,721 | -11,140 | 11,027 | -7,929 |
| Beginning Cash Position | 237,688 | 217,234 | 250,535 | 178,952 | 146,733 |
| End Cash Position | 315,937 | 237,688 | 217,234 | 250,535 | 178,952 |
| Net Cash Flow | $78,249 | $20,454 | $-33,301 | $71,583 | $32,219 |
| Free Cash Flow | |||||
| Operating Cash Flow | 160,401 | 126,733 | 152,119 | 123,774 | 136,891 |
| Capital Expenditure | -15,094 | -16,569 | -11,433 | -13,220 | -32,698 |
| Free Cash Flow | 145,307 | 110,164 | 140,686 | 110,554 | 104,193 |